Anti-hyperglycemic effect of bran extracts of two traditional rice varieties on alloxan-induced diabetic rats by Tanko, Abubakar  Sadiq & MARIKKAR, NAZRIM 
Indian Journal of Traditional Knowledge 
Vol 20(3), July 2021, pp 707-715 
Anti-hyperglycemic effect of bran extracts of two traditional rice varieties on 
alloxan-induced diabetic rats 
Abubakar Sadiq Tanko
a,b
 & Nazrim Marikkar
a,c,
* 
aDepartment of Biochemistry, Universiti Putra Malaysia, 43400 UPM Serdang, Selangor DE, Malaysia 
bDepartment of Biochemistry, Faculty of Sciences, Bauchi State University Gadau, PMB 65, Bauchi, Nigeria 
cNational Institute of Fundamental Studies, Hanthana Road, Kandy, Sri Lanka 
E-mail: nazrim.ma@nifs.ac.lk
Received 05 May 2020; revised 22 October 2020 
Beras merah (BM) and Beras hitam (BH) are two traditional rice varieties popular among the tribal communities living in 
Ba’kelalan region of Sarawak, East Malaysia. They are grown in fertile paddy lands at 3000 feet above the sea level 
according to the traditional farming system. In this study, we attempted to investigate the impact of oral administration of 
bran extracts (RBE) of B. merah and B. hitam on Alloxan-induced diabetic rats. Four-week long treatment of animals with 
RBE of varying doses (400 and 200 mg/kg) were monitored using anti-hyperglycemic activity and several blood parameters. 
Changes in body weight and blood parameters, which include blood glucose, liver enzymes and blood proteins, were also 
assessed using relevant assays. Results showed that RBEs of both B. merah and B. hitam possessed good antidiabetic 
potentials. The group administered with 400 mg/kg of B. merah (BM 400) showed the highest antidiabetic efficacy 
compared to 200 mg/kg of the same extract (BM 200). However, RBE of B. hitam displayed anti-hyperglycemic activity 
only at moderate level. It can be concluded that traditional rice variety B. merah would be a good potent sources of natural 
anti-diabetic agents. 
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Diabetes mellitus is a metabolic disorder of 
carbohydrate metabolism characterized by chronic 
hyperglycemia, resulting in the inability of 
human pancreas to produce enough insulin or 
the cells poor response for insulin
1,2
. As at 2019, 
about 9.3% of the world adult population was 
reportedly living with diabetes and it has been 
predicted that this will rise to almost 11% by 2045
3
. 
Prevalence of diabetes among Malaysian adult 
population aging above 30 years has been increasing 
perpetually from 8.3 to 14.9 to 18.3% in 1996, 2006 
and 2019, respectively
4,5
. According to Wan 
Nazaimon et al.
6
, the overall prevalence of diabetes 
in the country was around 22.9% of the total 
population in 2013. Stress, sedentary lifestyle, 
increased obesity and unhealthy eating pattern are 
identified as contributing factors for increasing 
diabetes during the past two decades
7
. Failure to arrest 
the rising trend in diabetes in the country would 
negatively impact the health of the nation, social 
welfare of the people and economic status due to 
diabetic complications that might ensue.  
Malaysia being an Asian country produces several 
hybrid rice varieties for white rice consumptions. For 
cooking purpose, most of the eateries and household 
use polished rice which gives an appealing white 
colour. Polishing helps remove the outer bran layer of 
the rice grain during milling of rice. According to a 
review by Sivamaurthi et al.
8
, bran of rice is identified 
as one of the nutrient-rich by-products generated in 
abundance by the rice processing sector. It is 
generally believed that the brans of traditional 
pigmented rice are far better than those of commercial 
hybrid rice owing to occurrence of high amounts of 
tocopherols, tocotrienols, γ-oryzanol, unsaturated 
fatty acids etc
9
. Despite these merits, traditional rice 
consumption is still not popular among the main 
stream Malaysian public probably due to lack of 
promotional campaigns and scarcity of information 
related to their nutritional values. As a matter of fact, 
traditional rice varieties are considered to be toxic-
free since they do not require excessive use of 
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fertilizer or pesticides due to drought tolerance and 
resistance for pest and diseases. As the chances of 
agrochemical exposure is minimal, traditional rice 
consumption can be a solution to address increasing 
cancer incidence among consumers. Research has 
provided ample evidence for the benefits of bioactive 
constituents of rice bran, which are attributed for 
multiple health claims on human subjects
8
.  
Malaysian rice germplasm consists of mainly hybrid 
rice along with several indigenous varieties namely, 
Adan halus (AH), Adan kasar (AK), Salleh halus (SH), 
Salleh Kasar (SK), Beras merah (BM), Beras hitam 
(BH) and Nanung (NNG)
10,11
. Some of these traditional 
rice varieties are confined to indigenous ethnic groups 
living in the Sarawak region of Malaysia where rice 
farming is done mainly using traditional, 
unmechanized methods. Conducive climate at 3000 
feet above the sea level and fertile virgin soil in 
Ba’kelalan region of Sarawak provide many 
opportunities for the tribal community to cultivate and 
self-sustain with these traditional rice varieties. Low 
level of literacy among the tribal communities and 
remote location of Ba’kelalan region for public access 
had hindered previous scientific investigations on 
traditional rice varieties. According to a preliminary 
assessment undertaken recently, out of the seven 
different traditional rice varieties investigated, rice 
brans of B. merah and B. hitam were found to exhibit 
highest antioxidative and anti-hyperglycemic 
properties
10
. Nonetheless, further exploration of these 
findings using an animal-based in vivo study was not 
performed previously to confirm the above mentioned 
claim about RBEs on diabetic subjects. Hence, this 
study was aimed to investigate the anti-hyperglycemic 
potential of RBEs of B. merah and B. hitam on 
normoglycemic and alloxan-induced diabatic rats. 
 
Materials and Methods 
 
Rice bran sampling 
Bran samples of two varieties of Malaysian 
traditional rice namely, B. merah (BM) and B. hitam 
(BH) were collected in triplicate from milling factories 
located at Ba’kelalan region of Sarawak, Malaysia. 
Samples sieved for extra-fine uniform particles of  
less than 325 mesh were heat-treated for 2 min at  
2450 MHz using a convection oven and kept under 
refrigerated condition (4-5°C) until further analysis.  
 
Experimental animals  
For the experiment, healthy male Sprague Dawley 
rats (180-220 g) with no prior drug treatment were 
procured from Saintifik Enterprise Sdn Bhd, Selangor 
D. E., Malaysia. They were kept in ventilated cages 
and fed with a normal commercial pellet diet and 
water ad libitum for two weeks to acclimatize prior to 
the commencement of the study. 
 
Ethical consideration 
This study was performed in compliance to the 
Malaysian Guidelines for Good Clinical Practice. The 
prior approval for the protocol was granted by the 
Institutional Animal Care and Use Committee 
(IACUC) of Universiti Putra Malaysia (UPM) giving 
the registration number; Reg. No. UPM/IACUC/ 
AUP-R023/2015. 
 
Preparation of RBEs 
Ten grams of each sample, after being soaked for 
24 h, was extracted with 70:30 ethanol: water (V/V) 
mixture at room temperature. The extract was then 
centrifuged with Eppendorf 8510R centrifuge 
(Eppendorf, Germany) at 8300 rpm speed for 10 min 
and filtered with Whatman # 1 filter paper. The 
solvent was subsequently evaporated under reduced-
pressure using a Buchi Model R-205 rotary 
evaporator (Buchi, Switzerland). The semisolid 
extracts (RBEs) were frozen at -20 ± 1°C for 24 h and 
subsequently freeze-dried using Virtis bench-top pro 
freeze dryer SJIA-10N (FD-1B-50) (Virtis, New 
York) for 3 days until they were completely dried. 
Portions of each freeze-dried RBEs were dissolved in 
water to prepare different doses required to administer 
in the animals. 
 
Study of anti-hyperglycemic activity of RBEs 




adopted with modification to
 
assess the anti-
hyperglycemic activity of the bran extracts in  
glucose loaded hyperglycemic animals. In brief,  
forty-eight animals fasted for 16 h were assigned 
randomly into 4 equal groups (n = 12/group). They 
were divided randomly into six treatment groups  
(n = 7) and administered with BM and BH extracts  
at different concentrations as described here: Group I: 
Normal control animals received vehicle only  
(10 mL/kg b.w); Group II: Animals treated with BH 
400 mg/kg b.wt; Group III: Animals treated with BH 
200 mg/kg b.wt; Group IV: Animals treated with BM 
400 mg/kg b.wt; Group V: Animals treated with BM 
200 mg/kg b.wt.); Group VI: Animals treated with 
Glibenclamide (10 mg/kg b.wt.). After 30 min of oral 
dosing, the animals were fed with glucose (2 g/kg 
b.w.) orally using gastric intubation. Samples of blood 




were withdrawn from the tail at 0, 30, 60 and 120 min 
of glucose administration. Blood Glucose Level 
(BGL) were estimated by the glucose oxidase 
enzymatic method using a commercial Accu-check 
active glucometer and test-strips. Water was used as a 
vehicle since all samples were soluble in water. 
 
Study of anti-diabetic activity of RBEs 
Diabetes was induced with a single intraperitoneal 
injection of 100 mg/kg of alloxan monohydrate  
to the over-night fasted (8 h) animals. Animals were 
divided randomly into 7 groups having five animals 
each (n = 5) based on treatments given. BGL of the 
induced animals were measured with Accu-check 
active glucometer from tail pinch 72 h after 
alloxanization; animals with fasting BGL of 200 mg/dL 
and above were identified as diabetic. The selected 
animals were randomly divided into seven treatment 
groups (n = 7) and administered the treatments as 
described here: Group I: Positive control group of 
diabetic animals treated with 5 mg/kg of 
Glibenclamide; Group II: Negative control group of 
non treated diabetic animals; Group III: Normal 
control group of non diabetic animals; Group IV: 
Diabetic animals treated with 400 mg/kg B. merah 
alcoholic extract; Group V: Diabetic animals treated 
with 200 mg/kg B. merah alcoholic extract; Group VI: 
Diabetic animals treated with 400 mg/kg B. hitam 
alcoholic extract; Group VII: Diabetic animals treated 
with 200 mg/kg B. hitam alcoholic extract. Body 
weights and blood glucose levels of the animals were 
measured at three (3) days interval until the final day 
(28
th
 Day) of the studies. On the final day of the 
experiment, the animals fasted-overnight were 
sacrificed by terminal bleeding through cardiac 
puncture after anaesthesia injection.  
 
Determination of blood biochemical parameters 
After the period of experimentation, the animals 
fasted-overnight were sacrificed under anaesthesia. 
Blood samples were withdrawn through cardiac 
puncture with the aid of sterile syringes and needles 
and dispensed into sterile tubes. The blood was allowed 
to clot for few hours after which it was subjected to 
centrifugation at 3, 500 rpm for 30 min in order to 
separate the serum from the whole blood. Serum was 
removed with sterile needles and syringes and then 
stored in a freezer until further analysis. Estimation of 
other biochemical parameters namely, Alanine amino 
transferase (ALT), Triglycerides (TAG), total protein 
(TP) and Albumin/globulin (ALB) were carried out by 
standard enzymatic methods using Hitachi 902 
automated biochem analyser.  
 
Statistical analysis 
All measurements of the experiment were carried out 
in triplicate data (n = 3) and the data were presented  
in mean ± standard deviation (SD). Results were 
statistically analysed using one-way analysis of  
variance (ANOVA) with IBM SPSS software package 
(version 21.0). When F values were significant, mean 
differences were compared using Duncan’s multiple 




Anti-hyper glycemic activities of RBEs  
Results of normo-glycemic studies conducted on 
rats with intact pancreas are shown in Table 1. Before 
administering the extracts, no significant (p>0.05) 
difference was noticed among all groups with regard 
to their fasting BGL. After 30 min of administration 
of 2 g/kg glucose, there was a significant (p<0.05) rise 
in the BGL of all groups. Moreover, significant 
(p<0.05) differences in BGL were noticed after  
120 min of administration among different groups 
treated with different extracts. The group treated with 
the known antidiabetic drug, glibenclamide showed 
the lowest BGL, which was significantly (p<0.05) 
lower than those of any other group. Interestingly, 
BGL of all groups treated with different doses of  
RBE extracts were found to be significantly (p<0.05) 
Table 1 — Effect of rice bran extracts of BH and BM on BGL (mg/dL) of glucose-loaded hyperglycemic rats 
Time (Min) BM400 BM200 BH400 BH200 GBLMD NEG 
0 87.8 ± 9.2a 85.8 ± 6.7a 82.2 ± 7.3a 86.2 ± 5.0a 84.0 ± 3.1b 88.6 ± 4.4a 
30 119.8 ± 8.3b 116.8 ±7.3b 108.8 ± 8.9a 146.4 ± 6.1c 109.4 ± 8.1a 121.2 ± 4.2b 
60 92.6 ± 6.1ba 102.8 ± 6.5c 118.6 ± 2.7d 126.80 ± 3.6e 84.4 ± 4.2a 118.2 ± 7.3c 
90 95.6 ± 8.5b 92.6 ± 2.1b 107.4 ± 4.6c 113.8 ± 5.0d 50.6 ± 2.7a 107.0 ±7 .7c 
120 80.6 ± 4.4b 82.8 ±5.6b 89.8 ± 5.8b 88.4 ± 9.1b 42.6 ± 4.6a 101.0 ± 7.5c 
The values represent Mean ± Standard deviation triplicate analysis. Means within each raw bearing different superscript are significantly 
(p<0.05) different. Abbreviations: BGL: blood glucose level; NEG: Negative control administered with water, BM400: Group treated 
with 400 mg/kg of Beras merah, BM200: Group treated with 200 mg/kg of Beras merah, BH400: Group treated with 400 mg/kg of Beras 
hitam, GBLMD: Group treated with 5 mg/kg of glibenclamide. 




lower than that of the negative control group. In 
addition, the group treated with BM400 mg/kg extract 
exhibited the lowest BGL when compared to any 
other RBE treated group. This showed that RBE  
of B. merah was dose dependent and dose level  
of 400 mg/kg displaying the highest hypoglycemic 
activity. The fall in BGL seen among RBE treated 
groups could be due to insulin mimetic activities 
exhibited by the RBEs which facilitated the fast 
absorption of glucose into the tissues and organs 
requiring them. 
 
Anti-diabetic activities of RBEs  
Data presented in Table 2 shows the results of 
changes in fasting BGL among different diabetic 
groups induced with single injection of alloxan 
monohydrate. Prior to inducing animals with alloxan, 
the fasting BGL of the rats in all groups were within 
the normal physiological range. After three days of 
the injection, rats in all induced groups exhibited 
hyperglycemia; their fasting BGL were significantly 
(p<0.05) higher than that of non alloxanized group. 
After confirmation of diabetic status of the rats, 
treatment continued until the 28
th
 day of the study 
(last day). All diabetic groups treated with different 
doses of the RBEs (BH400, BM400, BH200 and 
BM200) responded differently throughout the course 
of the treatments. According to the BGL of the last 
day of this experiment, none of the diabetic treated 
groups had their BGL normalized to those of the non 
alloxanized group. Although there was a gradual 
decline in the BGL of all treated groups, their values 
were significantly (p<0.05) higher than that of the 
non-treated normal control group. In fact, the results 
shown by RBE of B. merah is encouraging as it was 
dose dependent with the dose of 400 mg/kg showing 
the highest hypoglycemic activity. 
 
Changes in body weight 
Changes in body weights of Alloxan-induced 
diabetic group and the normal control group before 
and after treatments are compared as shown in  
Table 3. Prior to the induction of diabetes, animals  
in all groups did not show any significant (p<0.05) 
difference with regard to their body weights. 
Remarkable decreases in body weight were observed 
Table 2 — Changes in fasting BGL (mg/dL) of different groups of diabetic rats 
Day N.A. GBLMD NEG BH400 BH200 BM400 BM200 
1 78 ± 2.9b 79.6 ± 2.1ab 81.0 ± 2.4ab 79.8 ± 6.2ab 81.8 ± 2.4ab 82.4 ± 1.3a 80.6 ± 2.4ab 
4 78.8 ± 4.1d 223.2 ± 24.1bc 232.6 ± 19.4bc 210.6 ± 11.6c 244.6 ± 16.2b 269.2 ± 30.1a 222.8 ± 2.9bc 
7 77.0 ± 8.6d 132.4 ± 30.7c 224.6 ± 6.2b 224.2 ± 5.1b 252.4 ± 15.5a 256.2 ± 28.8a 228.2 ± 5.4b 
10 71.8 ± 13.1e 114.4 ± 15.1d 217.2 ± 4.2bc 232.6 ± 11.2ab 241.0 ± 21.8a 238.2 ± 20.8a 211.4 ± 6.8c 
13 79.4 ± 9.0e 108.0 ± 8.1d 225.8 ± 5.8ab 225.6 ± 5.77ab 231.2 ±12.8a 214.6 ± 17.7bc 202.8 ± 15.5c 
16 78.2 ± 6.1f 108.8 ± 8.2e 232.8 ± 5.9a 226.2 ± 3.3a 205.6 ± 13.0b 191.6 ± 9.3c 173.05 ± 19.2d 
19 70.2 ± 6.1e 98.0 ± 12.4d 235.6 ± 7.1a 197.8 ± 12.0b 196.4 ± 21.0b 181.0 ± 13.0b 146.2 ± 15.3c 
22 83.0 ± 7.5f 102.6 ± 11.8e 240.4 ± 6.5a 185.6 ± 16.8b 194.4 ± 17.7b 165.6 ± 10.4c 136.4 ± 13.2d 
25 73.2 ± 10.6g 89.4 ± 6.0f 243.0 ± 8.8a 162.8 ± 8.2c 183.0 ± 8.2b 143.6 ± 14d 128.4 ± 7.5e 
28 79.4 ± 11.4f 94.2 ± 12.7e 246.2 ± 4.2a 149.4 ± 7.1c 184.6 ± 8.7b 117.0 ± 5.2d 125.4 ± 7.1d 
Data are presented as Mean ± Standard deviation. Means within rows with different superscripts are significantly different (at p<0.05). 
Abbreviations: BGL: blood glucose level; BM400: Group treated with 400 mg/kg of Beras merah, BH400: Group treated with 400 mg/kg 
of Beras hitam, BH200: Group treated with 200 mg/kg of Beras hitam, BH200: Group treated with 200 mg/kg of Beras hitam, GBLMD: 
Group treated with 5mg/kg of glibenclamide, NEG: Negative control administered with water; N.A. Normal control. 
 
Table 3 — Changes in body weights (g) of different groups of rats starting from 1st until 28th day of the study 
 1st Day - Body weight (g) 28th Day - Body weight (g) % Change in body weight 
Normal control 215.4 ± 13.4a 275.4 ± 8.4b +27.85 
Diabetic control 212.60±16.55a 169.00±21.21a -20.51 
Diabetic+ BH (400 mg/Kg b.wt.) 210.29±14.9 a 192.00±5.66c -8.70 
Diabetic+ BH (200 mg/Kg b.wt.) 212.43±15.00 a 199.25±29.94c -6.20 
Diabetic+ BM (400 mg/Kg b.wt.) 222.40±11.2a 209.80±28.55c -5.67 
Diabetic+ BM (200 mg/Kg b.wt.) 209.70±14.7 a 195.75±37.21c -6.65 
Diabetic+ Glibenclamide (5 mg/Kg b.wt.) 220.55±11.2a 217.00±32.01c -1.61 
Data are presented as Mean ± Standard deviation. Mean values with different superscripts within the column are significantly different 
(p<0.05). Abbreviations: BM400: Group treated with 400 mg/kg of Beras merah, BH400: Group treated with 400 mg/kg of Beras hitam, 
BH200: Group treated with 200 mg/kg of Beras hitam, BH200: Group treated with 200 mg/kg of Beras hitam, GBLMD: Group treated 
with 5 mg/kg of glibenclamide, NEG: Negative control administered with distilled-water. 
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among Alloxan-induced diabetic groups when 
compared to the normal control group, which 
exhibited a significant (p<0.05) increase by 27.85%.  
Biochemical parameters 
Liver enzymes 
The results presented in Table 4 compare the 
effects of different treatment of RBEs on biochemical 
parameters namely alanine amino transferase (ALT), 
total protein (T.P), albumin (ALB) and triglycerides 
(TAG) of alloxan induced diabetic rats. ALT is a liver 
specific enzyme whose levels in blood exceeding the 
normal range will be indicative of hepatic necrosis. 
According to results, alloxan induced-diabetic groups 
had displayed significantly (p<0.05) higher alanine 
amino transferase levels when compared to the non 
alloxanized groups. However, between the positive 
control group and the non alloxanized group, there 
was no significant (p>0.05) difference. This showed 
that the positive controlled group treated with 
glibenclamide had their ALT levels lowered close to 
the non alloxanized groups. Although the BM400 
exhibited a significantly higher enzyme levels than 
the non alloxanized group, there was no significant 
(p>0.05) difference between the BM400 and the 
positive controlled group with regard to their ALT 
levels. This shows that the concentration of BM at 
400 mg/kg is found to be almost as potent as 
glibenclamide at 5 mg/kg. The other two groups 
namely BH200 and BM200 showed no significant 
difference in ALT levels with the negative control 
group indicating a low potency of anti-diabetic 
activities. 
Triglycerides 
According to results presented in Table 4, the 
control group (NEG) displayed significantly (p<0.05) 
higher levels of triglycerides when compared to any 
other treated group. All other treated groups also had 
significantly (p<0.05) higher triglycerides levels when 
compared to the normal group except groups treated 
with glibenclamide and BM400. However, the 
remaining groups namely, BH400, BH200 and 
BM200 were able to show potentials of lowering of 
high blood triglycerides. These results further 
confirmed that the rise in BGL of alloxan-induced 
diabetic animals was accompanied by a rise in serum 
triglyceride levels. The abilities of the RBEs to reduce 
diabetic hypertriglyceridemia could be due to their 
potentials of controlling hyperglycemia.  
Total blood protein and albumin 
Results of the total protein and albumin of blood 
samples from different groups are shown in Table 4. 
Among the different groups, there was hardly any 
significant (p>0.05) difference with regard to total 
protein and albumin content.  
Discussion 
Anti-hyperglycemic properties 
Addressing diabetes in the early stage of incidence 
is always important to prevent long-term 
complications leading to severe damages to body’s 
systems including blood vessels and nerves
13
. Making 
an effort to maintain the blood glucose level within 
the normal range would help prevent persistence of 
hyperglycemia and minimize complications linked to 
diabetes
14
. One important approach in the management 
of diabetes is to control the postprandial BGL 
by inhibiting the activities of the carbohydrate 
hydrolysing enzymes in the small intestine through 
drugs. To date, several synthetic drugs have been used 
as inhibitory agents as they possess the ability to bind 
to the active sites of the enzymes to inhibit their 
catalytic activities thereby causing a decrease in the 
release of glucose from carbohydrate digestion
15
. As 
alternatives for synthetic anti-diabetic drugs, which 
have been implicated for many side effects, natural 
anti-diabetic agents especially from traditional 
medicinal or dietary plants have been explored by 
Table 4 — Effect of different treatments on biochemical parameters of Alloxan induced diabetic rats on the 28th day of treatment 
Parameters N.A. GBLMD NEG BH400 BH200 BM400 BM200 
ALT (U/L) 36.5 ± 9.2e 54.7 ± 3.0d 94.2 ± 14.9a 74.4 ± 18.8bc 83.2 ± 7.9ab 56.3 ± 9.6cd 78.3 ± 24.2ab 
TAG (mg l/dL) 14.2 ± 2.6i 15.0 ± 1.3hi 31.5 ± 3.3f 19.0 ± 2.7gh 20.2 ± 6.9g 15.7 ± 1.5hi 18.7 ± 0.3gh 
T.P. (g/L) 77.7 ± 3.4jk 79.7 ± 3.8jk 81.1 ± 3.0jk 76.7 ± 6.1k 83.0 ± 4.4j 79.9 ± 4.4jk 76.8 ± 4.3k 
ALB (g/L) 36.8 ± .9lm 38.8 ± 2.4lm 39.7 ± 1.2l 34.8 ± 6.9lm 38.6 ± 2.2lm 35.3 ± 3.5lm 34.3 ± 5.9lm 
Each value presented as Mean ± Standard deviation. Mean values with different superscripts in the same row are significantly different 
(p<0. 05). Abbreviations: BM400: Group treated with 400 mg/kg of Beras merah; BH400: Group treated with 400 mg/kg of Beras hitam; 
BM200: Group treated with 200 mg/kg of Beras merah; BH200: Group treated with 200 mg/kg of Beras hitam; GBLMD: Group treated 
with 5 mg/kg of glibenclamide; NEG: Negative control administered with distilled water; ALT: Alanine amino transferase; ALB: 
Albumin, TAG: Triglycerides, T.P.: Total protein. 






. Liyanagamage et al.
16
 
recently compiled the studies performed to investigate 
the uses of traditional medicinal plants for glycemic 
control among diabetic subjects. According to the 
traditional system of medicine such as Ayurveda and 
Siddha, use of extracts of medicinal plants is found to 
be effective for diabetic control. Apart from taking 
medicinal extracts, diabetic patients are advised to 
consume traditional food or drinks such as chyme 
prepared with Osbeckia octandra, curries prepared 
with Lassia spinos, salads prepared with Centella 
asiatica, spices of Trigonella foenum-graecum, fruits 
of Phyllanthus embelica and drink of Camellia sinesis 
as a part of their diet
17
. In place of wheat flour, food 
products based on millet, legumes and fenugreek 
seeds are considered to be beneficial as diabetic diet. 
Consumption of fenugreek seeds, for instance, as a 
supplement on a daily basis has been shown to 
provide antidiabetic effect among prediabetes. 
Recently, Gaddam et al.
18
 reported that the dietary 
intake of 10 g fenugreek seeds/day in prediabetes 
subjects could help to lower the rate of conversion 
into diabetes. Among the different types of Sri Lankan 
rice, traditional varieties such as Goda Heeneti, Sudu 
Heeneti, Dik Wee and Masuran are found to be good 
sources of essential minerals, vitamins, amino acids, 
insoluble fibre and coloured pigments
19
. As such, they 
were reported to display lower glycemic index (GI), 
which is beneficial to maintain glycemic control 
among diabetic subjects
20
. This observation was 
reaffirmed through another study conducted using  
the traditional rice varieties of Malaysia, where the 
RBEs of B. merah and B. hitam exhibited inhibitory 
effects on carbohydrate hydrolyzing enzymes, which 
implied their potency to be used in diabetic 
management
10
. In the application side, Godakumbura 
et al.
21
 suggested that use of traditional rice grain with 
its bran in herbal porridge would make the product 
more nutritious and healthier. 
Animal models are frequently employed as tools to 
assess the therapeutic potential of novel anti-diabetic 
agents. Although several synthetic drugs are 
employed to induce diabetes in animals, Alloxan 
monohydrate and Streptozotocin have become most 
prominent among researchers due to their efficacy
22
. 
In our study, Alloxan monohydrate was chosen as 
diabetogenic drug due to its low-cost. According to 
Makheswari & Sunderam
23
, a single injection of 
alloxan at a dose of 140 – 180 mg/kg (5% w/v), 
usually 150 mg/kg intraperitoneally is sufficient to 
induce diabetes in rats after fasting of at least eight (8) 
hours. When administered to animals like mice, rats, 
rabbits and dogs, it accumulates in the pancreatic beta 
cells and is subsequently taken up via the GLUT2 
glucose transporter
24
. Alloxan is believed to cause 
excess production of reactive oxygen species leading 
to cytotoxicity in pancreatic beta cells, which reduces 
the synthesis and release of insulin
25
. As a result, 
increase in BGL will occur owing to lack of 
absorption of glucose by the cells, which would force 
the cells to utilize fatty acids and amino acids as 
energy source, thereby leading to the reduction of fat 
and proteins in the body
26
. Naito et al.
27
 further stated 
that the body weight losses in diabetic animals can 
also happen due to non-enzymatic glycosylation 
prompted by hyperglycemia since non-enzymatic 
glycosylation is one of the processes that lead to 
depreciation of body protein. 
Normo-glycaemic studies of our investigation 
aimed at seeing the efficacy of RBEs to counter the 
increasing BGL after a glucose load without actually 
tempering with the pancreatic islets
28
. At thirty 
minutes after glucose administration, the BGL peaked 
rapidly from fasting BGL value, but then 
subsequently decreased. Rapidity in postprandial 
hyperglycemia is a normal physiological process in 
the body, but its persistence would be deleterious. 
Both RBEs exhibited considerable potential to bring 
down the BGL remarkably after 120 min of 
administration. Antioxidants present in the RBEs 
could be possibly helping to normalize the rising 
blood glucose level through inhibition of alpha 
amylase. This is in conformity with the findings 
reported by Yao et al.
29
 and Premakumara et al.
20
 who 
previously discussed the inhibitory potentials of rice 
bran on carbohydrate digestive enzymes.  
In the present study, all diabetic groups exhibited 
hyperglycemia after three days of inducing alloxan. 
The spike in fasting BGL observed among diabetic 
groups would be probably due to damages in the  




gradual decline in the levels of blood glucose among 
all treated groups was observed due to the effect of 
RBEs especially RBE of B. merah. According to the 
preliminary results of our investigation, RBEs of both 
B. merah and B. hitam were found to be potent in 
inhibiting carbohydrate hydrolyzing enzymes; this 
was attributed to bioactive compounds occurring in 
pigmented rice
9
. Yao et al.
29
 previously found that 




anthocyanin contents of coloured grains are higher 
than those of the white grains, which might help in the 
inhibition of enzymes hydrolyzing carbohydrates. 
According to another study by Manoharan et al.
31
, 
oral administration of ethanolic extract of plant 
Pippali (Piper longum L.) restored the normal BGL in 
diabetic rats within 45 days, which indicated that the 
extract stimulated the normal homeostasis of blood 
glucose in diabetes.  
Blood parameters generally serve as important 
biomarkers in determining the function or impairment 
of certain body organs. After studying the hepato-
renal protective and anti-diabetic effects of 
ziyuglycoside II methyl ester in Type 2 diabetic mice, 
Son et al.
28 
stated that the rise in ALT levels of the 
mice was due to hepatic necrosis which could 
exacerbated by diabetes progression. However, 
Navarro et al.
32 
argued that the increase in the 
activities of the enzymes was mainly due to outflow 
of the enzymes caused by leakage from the cytosol of 
the liver into the blood stream as a results of hepatic 
necrosis which might have resulted from alloxan 
toxicity. In our study, administration of RBEs to the 
individual treatment groups indicated a decline in the 
enzyme activities towards normalcy. Yousef & El-
naga
33
 previously made similar observations while 
studying the effect of garlic oil on the levels of 
various enzymes in the serum. The abilities of the 
RBEs especially BM400 to lower the levels of the 
liver enzymes was likely due to antioxidant activities 
of the extracts which prevented further generation of 
the hepatic cells by formation of free radicals through 
alloxan induced peroxidation. The ability displayed 
by B. merah at 400 mg/kg showed it as a potential 
anti-diabetic agent to prevent or curb diabetic 
complication. 
Diabetes is reported to have a strong nexus with 
impaired metabolism of lipids, which could cause an 
increase in the levels of blood lipids putting diabetes 
patients at risk of complications like atherosclerosis
34
. 
According to Barrett & Udani
35
, insulin stimulates the 
uptake of blood glucose into cells of the skeletal 
muscle and liver where they are stored in the form of 
glycogen. It is also responsible for increase in fatty 
acid synthesis for storage purpose. However, decrease 
in insulin sensitivity or resistance was said to cause 
deposition of lipids in liver and skeletal muscle 
thereby increasing insulin resistance which exacerbate 
the chances of developing or worsening Type-2 
diabetes and heart disease. A decrease in the amounts 
of blood protein is usually caused in conjugation with 
glucose and protein peroxidation, both of which 
progress during the state of chronic hyperglycemia 
and oxidative stress. This phenomenon is quite 
prevalent especially among diabetic patients. 
Moreover, both processes that lead to fall in protein 
usually take a longer period of time before beginning 
to expose
12,36
. In the present study, maintenance of 
protein to near normal level could be due to the effect 
of RBEs on blood glucose levels that lead to the non-
progression of processes like protein oxidation and 
glycation, both of which can lead to a decline in blood 
protein in the state of chronic hyperglycemia
26
. It 
could also be partly due to the shorter time period of 
this study, which is less than 3 months. This might not 
give the actual protein levels as affected due to the 
processes like glycation, which would normally last 
for at least three (3) months before indication to be 
seen in the protein levels.  
 
Conclusions 
Brans of the two traditional rice varieties of this 
study are highly useful as nutraceutical as well as 
functional food because the oral administration of the 
RBEs of them was found to be effective in gradual 
reduction of BGL in Alloxan induced diabetic rats. 
This is in conformity with the preliminary results 
obtained for α-amylase and α-glucosidase assays of 
RBEs of these two rice types. Out of the two 
traditional rice bran types investigated, B. merah was 
found to emerge as a more potent anti-hyperglycemic 
agent. Although weight losses were common among 
most of the Alloxan-induced animal groups, 
restoration of their blood biochemical parameters to 
near normal levels was attained after treatment with 
RBEs especially B. merah. The overall findings 
suggest that rice from these two varieties with their 
bran can become base material for functional foods 
such as herbal rice porridges, rice noodles, rice 
crackers etc. If active compounds responsible for the 
antidiabetic and antioxidative activities of these two 
traditional rice brans are discovered, they can be 
isolated and used as active ingredients for 
pharmaceutical purposes or drug development.  
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